(L)-ASPARTIC ACID
Brand names,
(L)-ASPARTIC ACID
Analogs
(L)-ASPARTIC ACID
Brand Names Mixture
(L)-ASPARTIC ACID
Chemical_Formula
C4H7N1O4
(L)-ASPARTIC ACID
RX_link
No information avaliable
(L)-ASPARTIC ACID
fda sheet
(L)-ASPARTIC ACID
msds (material safety sheet)
(L)-ASPARTIC ACID
Synthesis Reference
No information avaliable
(L)-ASPARTIC ACID
Molecular Weight
133.104 g/mol
(L)-ASPARTIC ACID
Melting Point
230 oC
(L)-ASPARTIC ACID
H2O Solubility
4.5 g/l
(L)-ASPARTIC ACID
State
Solid
(L)-ASPARTIC ACID
LogP
-0.67 +/- 0.36
(L)-ASPARTIC ACID
Dosage Forms
Capsules and powder
(L)-ASPARTIC ACID
Indication
There is no support for the claim that aspartates are exercise performance enhancers, i.e. ergogenic aids.
(L)-ASPARTIC ACID
Pharmacology
L-aspartate is considered a non-essential amino acid, meaning that, under normal physiological conditions, sufficient amounts of the amino acid are synthesized in the body to meet the body's requirements. L-aspartate is formed by the transamination of the Krebs cycle intermediate oxaloacetate. The amino acid serves as a precursor for synthesis of proteins, oligopeptides, purines, pyrimidines, nucleic acids and L-arginine. L-aspartate is a glycogenic amino acid, and it can also promote energy production via its metabolism in the Krebs cycle. These latter activities were the rationale for the claim that supplemental aspartate has an anti-fatigue effect on skeletal muscle, a claim that was never confirmed.
(L)-ASPARTIC ACID
Absorption
Absorbed from the small intestine by an active transport process
(L)-ASPARTIC ACID
side effects and Toxicity
Mild gastrointestinal side effects including diarrhea. LD50 (rat) > 5,000 mg/kg.
(L)-ASPARTIC ACID
Patient Information
No information avaliable
(L)-ASPARTIC ACID
Organisms Affected
Humans and other mammals